DNA synthesis machinery and nucleic acids

The DNA synthesis machinery and nucleic acids in proliferating cells represent a collective group of molecular targets essential for genomic replication and cell division (NCI Dictionary, 2023). This complex includes enzymes such as DNA polymerases, which catalyze the synthesis of DNA molecules, and topoisomerases, which manage DNA supercoiling during replication (Alberts et al., Molecular Biology of the Cell, 2014). In oncology, these components are targeted because cancer cells exhibit high rates of proliferation compared to most normal cells (StatPearls, 2023). Drugs such as antimetabolites (e.g., 5-fluorouracil) interfere with the production of nucleotide precursors, while alkylating agents (e.g., cisplatin) directly damage the DNA template (PubMed: 28636591). Other agents, like topoisomerase inhibitors, induce lethal DNA strand breaks by trapping enzyme-DNA complexes (NIH, 2022). Because these targets are also essential for the maintenance of healthy, rapidly dividing tissues like bone marrow and the gut lining, treatment often results in significant systemic toxicities such as myelosuppression and mucositis. Despite these challenges, targeting the DNA synthesis machinery remains a cornerstone of systemic cancer therapy and antimicrobial treatment.

Other names

DNA replication machineryReplisomeNucleic acid synthesis componentsProliferating cell nuclear targets

Drugs targeting this machinery act through several mechanisms: antimetabolites inhibit the synthesis of nucleotide precursors; DNA polymerase inhibitors prevent strand elongation; alkylating agents and platinum compounds create DNA cross-links that block replication; and topoisomerase inhibitors prevent the relief of torsional strain during unwinding, leading to lethal DNA strand breaks.